GENEWIZ CEO and leadership

Amy Liao is a Co-Founder & Chief Executive Officer at GENEWIZ and President/COO/Co-Founder at GENEWIZ.

Conrad Leung is a Chief Scientific Officer at GENEWIZ and VP Operations at GENEWIZ and is based in New, York. He attended Columbia University between 1994 and 1999.

Dr. Gray joined Azenta Life Sciences in July 2014 after having consulted with the Company since November 2013. He leads our next generation product and business initiatives and is also responsible for corporate-level initiatives to guide our strategic moves. Prior to joining the company, Dr. Gray held the position of Chief Strategy and New Business Officer at GT Advanced Technologies, Inc., where he held various executive management roles and was responsible for global strategy development and execution as well as internal product development. He spent several years as an M&A and strategic advisor to various companies in the technology and life science industries.

Dr. Gray has a Bachelors degree in Chemical Engineering from Carnegie Mellon University, Masters and PhD degrees in Chemical Engineering from MIT, and an MBA degree from Stanford University.

Mr. Robertson joined Azenta Life Sciences on October 2013 as Executive Vice President and Chief Financial Officer. Mr. Robertson is responsible for leading and managing Azenta's global financial strategy including establishing long range financial planning and policies while maintaining positive relationships with our shareholders and the financial community.

Prior to joining Azenta, Mr. Robertson was Vice President and Chief Financial Officer of Graftech International, a $1.3 billion global provider of carbon and graphite products for industrial applications. Prior to Graftech International, he worked for the IBM Corporation for over 25 years in various senior financial management roles, including CFO of IBM's global hardware business and CFO of IBM's Japan and China operations.

Mr. Robertson holds an MBA from the University of North Carolina, Chapel Hill and an undergraduate degree in accounting from the University of Texas, Austin.

Mr. Paulo joined Azenta Life Sciences in July 2017 as Vice President and Chief Information & Digital Officer. As the Chief Information & Digital Officer Mr. Paulo provides the strategic vision, operational plan, and execution for the technology enablement of the business, enabling the continual positive transformation and progression of the global business.

Mr. Paulo began his career at Automatic Switch Co. in Florham Park New Jersey which was acquired by Emerson Electric Co. based in St. Louis Missouri. Over the course of the next twenty-seven years at Emerson, Mr. Paulo held increasing roles of global responsibility across several key divisions of Emerson, each serving different global industries from healthcare to data centers and telecom: CIO at ASCO Power Technologies, CIO at Energy Systems, CIO at Liebert, and CIO Americas and VP Global Transformation at Emerson’s Network Power business platform which became Vertiv, a $4B annual revenue global business with a footprint in over 147 countries.

Mr. Paulo received his Bachelor’s degree in Electrical Engineering and MBA from Rutgers University. He also holds several certifications spanning the Information Technology & Information Systems profession.

Amy Liao is a Co-Founder & Chief Executive Officer at GENEWIZ and President/COO/Co-Founder at GENEWIZ.